Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.

Peyvandi F, Mannucci PM, Garagiola I, El-Beshlawy A, Elalfy M, Ramanan V, Eshghi P, Hanagavadi S, Varadarajan R, Karimi M, Manglani MV, Ross C, Young G, Seth T, Apte S, Nayak DM, Santagostino E, Mancuso ME, Sandoval Gonzalez AC, Mahlangu JN, Bonanad Boix S, Cerqueira M, Ewing NP, Male C, Owaidah T, Soto Arellano V, Kobrinsky NL, Majumdar S, Perez Garrido R, Sachdeva A, Simpson M, Thomas M, Zanon E, Antmen B, Kavakli K, Manco-Johnson MJ, Martinez M, Marzouka E, Mazzucconi MG, Neme D, Palomo Bravo A, Paredes Aguilera R, Prezotti A, Schmitt K, Wicklund BM, Zulfikar B, Rosendaal FR.

N Engl J Med. 2016 May 26;374(21):2054-64. doi: 10.1056/NEJMoa1516437.

PMID:
27223147
2.

Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors.

López-Fernández MF, Altisent Roca C, Álvarez-Román MT, Canaro Hirnyk MI, Mingot-Castellano ME, Jiménez-Yuste V, Cid Haro AR, Pérez-Garrido R, Sedano Balbas C.

Thromb Haemost. 2016 May 2;115(5):872-95. doi: 10.1160/TH15-07-0568. Epub 2016 Feb 4.

PMID:
26842562
3.

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors.

Mingot-Castellano ME, Álvarez-Román MT, López-Fernández MF, Altisent-Roca C, Canaro-Hirnyk MI, Jiménez-Yuste V, Cid-Haro AR, Pérez-Garrido R, Sedano-Balbas C.

Eur J Haematol. 2016 May;96(5):461-74. doi: 10.1111/ejh.12730. Epub 2016 Feb 4. Review.

PMID:
26714021
4.

Experience of Preimplantation Genetic Diagnosis for Hemophilia at the University Hospital Virgen Del Rocío in Spain: Technical and Clinical Overview.

Fernández RM, Peciña A, Sánchez B, Lozano-Arana MD, García-Lozano JC, Pérez-Garrido R, Núñez R, Borrego S, Antiñolo G.

Biomed Res Int. 2015;2015:406096. doi: 10.1155/2015/406096. Epub 2015 Jul 16.

PMID:
26258137
5.

The spectrum of mutations in Southern Spanish patients with von Willebrand disease.

Álvarez-Laderas I, Núñez R, Jiménez-Bárcenas R, Rodriguez Martorell FJ, Garcia-Lozano JR, de Cos C, Pérez Garrido R.

Haemophilia. 2015 May;21(3):e240-2. doi: 10.1111/hae.12649. Epub 2015 Feb 17. No abstract available.

PMID:
25689060
6.

Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.

Clausen N, Petrini P, Claeyssens-Donadel S, Gouw SC, Liesner R; PedNet and Research of Determinants of Inhibitor development (RODIN) Study Group..

Haemophilia. 2014 Nov;20(6):747-55. doi: 10.1111/hae.12470. Epub 2014 Jun 3.

PMID:
24893572
7.

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study.

Gouw SC, van den Berg HM, Fischer K, Auerswald G, Carcao M, Chalmers E, Chambost H, Kurnik K, Liesner R, Petrini P, Platokouki H, Altisent C, Oldenburg J, Nolan B, Garrido RP, Mancuso ME, Rafowicz A, Williams M, Clausen N, Middelburg RA, Ljung R, van der Bom JG; PedNet and Research of Determinants of INhibitor development (RODIN) Study Group..

Blood. 2013 May 16;121(20):4046-55. doi: 10.1182/blood-2012-09-457036. Epub 2013 Apr 3.

PMID:
23553768
8.

Factor VIII products and inhibitor development in severe hemophilia A.

Gouw SC, van der Bom JG, Ljung R, Escuriola C, Cid AR, Claeyssens-Donadel S, van Geet C, Kenet G, Mäkipernaa A, Molinari AC, Muntean W, Kobelt R, Rivard G, Santagostino E, Thomas A, van den Berg HM; PedNet and RODIN Study Group..

N Engl J Med. 2013 Jan 17;368(3):231-9. doi: 10.1056/NEJMoa1208024.

PMID:
23323899
9.

Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.

Mariani G, Napolitano M, Dolce A, Pérez Garrido R, Batorova A, Karimi M, Platokouki H, Auerswald G, Bertrand AM, Di Minno G, Schved JF, Bjerre J, Ingerslev J, Sørensen B, Ruiz-Saez A; Seven Treatment Evaluation Registry.; International Factor VII Deficiency Study Group..

Thromb Haemost. 2013 Feb;109(2):238-47. doi: 10.1160/TH12-07-0476. Epub 2012 Dec 13.

PMID:
23238632
10.

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry.

Tengborn L, Baudo F, Huth-Kühne A, Knoebl P, Lévesque H, Marco P, Pellegrini F, Nemes L, Collins P; EACH2 registry contributors..

BJOG. 2012 Nov;119(12):1529-37. doi: 10.1111/j.1471-0528.2012.03469.x. Epub 2012 Aug 20.

PMID:
22901076
11.

Efficacy of factor IX Grifols(®) in surgery: experience of an international multicentre retrospective study.

Pérez-Garrido R, Alonso N, Jiménez-Yuste V, Haya S, Zúñiga P, Baques A, Candela M, Dávoli M, Rescia V.

Haemophilia. 2012 Sep;18(5):e372-3. doi: 10.1111/j.1365-2516.2012.02919.x. Epub 2012 Jul 30. No abstract available.

PMID:
22845857
12.

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.

Baudo F, Collins P, Huth-Kühne A, Lévesque H, Marco P, Nemes L, Pellegrini F, Tengborn L, Knoebl P; EACH2 registry contributors..

Blood. 2012 Jul 5;120(1):39-46. doi: 10.1182/blood-2012-02-408930. Epub 2012 May 22.

PMID:
22618709
13.

Pain management in patients with haemophilia: a European survey.

Holstein K, Klamroth R, Richards M, Carvalho M, Pérez-Garrido R, Gringeri A; European Haemophilia Therapy Standardization Board..

Haemophilia. 2012 Sep;18(5):743-52. doi: 10.1111/j.1365-2516.2012.02808.x. Epub 2012 Apr 25. Review.

PMID:
22530627
14.

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, Marco P, Tengborn L, Huth-Kühne A; EACH2 registry collaborators..

Blood. 2012 Jul 5;120(1):47-55. doi: 10.1182/blood-2012-02-409185. Epub 2012 Apr 18.

PMID:
22517903
15.

The international factor IX treatment network survey.

Berntorp E, Shapiro AD, Waters J, Astermark J; International Factor IX Treatment Network..

Haemophilia. 2012 May;18(3):e60-2. doi: 10.1111/j.1365-2516.2012.02767.x. Epub 2012 Mar 8. No abstract available.

PMID:
22404549
16.

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Knoebl P, Marco P, Baudo F, Collins P, Huth-Kühne A, Nemes L, Pellegrini F, Tengborn L, Lévesque H; EACH2 Registry Contributors..

J Thromb Haemost. 2012 Apr;10(4):622-31. doi: 10.1111/j.1538-7836.2012.04654.x.

PMID:
22321904
17.

Characterization of sequence breakpoints in two haemophiliac patients with large FVIII gene deletions.

Fernández-López O, García-Lozano JR, Núñez-Vázquez R, Pérez-Garrido R, Núñez-Roldán A.

Haemophilia. 2007 Sep;13(5):682-4. No abstract available.

PMID:
17880466
18.

First report of two independent point factorVIII mutations in a family with haemophilia a: a word of caution for carrier diagnosis.

Tizzano EF, Venceslá A, Baena M, Cornet M, Calvo MT, Lucía JF, Pérez Garrido R, Núñez R, Baiget M.

Thromb Haemost. 2005 Sep;94(3):675-7. No abstract available.

PMID:
16268489
19.

The spectrum of mutations in Southern Spanish patients with hemophilia A and identification of 28 novel mutations.

Fernández-López O, García-Lozano JR, Núñez-Vázquez R, Pérez-Garrido R, Núñez-Roldán A.

Haematologica. 2005 May;90(5):707-10.

PMID:
15921397
20.

Health status and health-related quality of life of children with haemophilia from six West European countries.

Gringeri A, von Mackensen S, Auerswald G, Bullinger M, Perez Garrido R, Kellermann E, Khair K, Lenk H, Vicariot M, Villar A, Wermes C; Haemo-QoL Study..

Haemophilia. 2004 Mar;10 Suppl 1:26-33.

PMID:
14987246

Supplemental Content

Loading ...
Support Center